CHINA PETE & CHEM (SNPMF) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 29, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2022, filed Apr 28, 2023. Each column of the statement tables below links to the filing it was taken from.
CHINA PETE & CHEM (SNPMF) reported $481.1B in revenue for fiscal year 2022, up 11.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
CHINA PETE & CHEM does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
CHINA PETE & CHEM passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.
For every $1 of reported earnings, CHINA PETE & CHEM generates $1.76 in operating cash flow ($16.9B OCF vs $9.6B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
CHINA PETE & CHEM earns $4.52 in operating income for every $1 of interest expense ($11.0B vs $2.4B). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
CHINA PETE & CHEM generated $481.1B in revenue in fiscal year 2022. This represents an increase of 11.9% from the prior year.
CHINA PETE & CHEM's EBITDA was $26.9B in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 18.4% from the prior year.
CHINA PETE & CHEM reported $9.6B in net income in fiscal year 2022. This represents a decrease of 15.1% from the prior year.
CHINA PETE & CHEM earned $0.08 per diluted share (EPS) in fiscal year 2022. This represents a decrease of 13.9% from the prior year.
Cash & Balance Sheet
CHINA PETE & CHEM held $13.5B in cash against $12.4B in long-term debt as of fiscal year 2022.
Not reported for fiscal year 2022.
Not reported for fiscal year 2022.
Margins & Returns
CHINA PETE & CHEM's operating margin was 2.3% in fiscal year 2022, reflecting core business profitability. This is down 1.2 percentage points from the prior year.
CHINA PETE & CHEM's net profit margin was 2.0% in fiscal year 2022, showing the share of revenue converted to profit. This is down 0.6 percentage points from the prior year.
CHINA PETE & CHEM's ROE was 8.4% in fiscal year 2022, measuring profit generated per dollar of shareholder equity. This is down 0.9 percentage points from the prior year.
Not reported for fiscal year 2022.
Capital Allocation
CHINA PETE & CHEM invested $1.9B in research and development in fiscal year 2022. This represents an increase of 2.8% from the prior year.
CHINA PETE & CHEM spent $605.9M on share buybacks in fiscal year 2022, returning capital to shareholders by reducing shares outstanding.
Not reported for fiscal year 2022.
SNPMF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $481.1B+11.9% | $430.1B+33.3% | $322.6B-24.1% | $424.9B+1.4% | $419.2B+15.6% | $362.8B+30.4% | $278.1B-10.8% | $311.9B |
| R&D Expenses | $1.9B+2.8% | $1.8B+16.5% | $1.5B+13.9% | $1.4B+16.7% | $1.2B+17.8% | $987.2M+15.4% | $855.7M-2.0% | $872.8M |
| Operating Income | $11.0B-26.0% | $14.8B+608.8% | $2.1B-83.1% | $12.4B+3.5% | $12.0B+9.3% | $11.0B-1.2% | $11.1B+26.7% | $8.8B |
| EBITDA | $26.9B-18.4% | $33.0B+77.8% | $18.6B-34.1% | $28.2B+0.4% | $28.1B-2.3% | $28.7B+7.4% | $26.7B+13.0% | $23.7B |
| Interest Expense | $2.4B+3.2% | $2.4B+1.2% | $2.3B-5.1% | $2.5B+128.2% | $1.1B-2.1% | $1.1B-17.3% | $1.3B+5.8% | $1.3B |
| Income Tax | $2.7B-25.7% | $3.7B+276.4% | $972.3M-62.5% | $2.6B-12.1% | $2.9B+17.9% | $2.5B-16.1% | $3.0B+53.2% | $1.9B |
| Net Income | $9.6B-15.1% | $11.3B+120.4% | $5.1B-38.0% | $8.3B-7.9% | $9.0B+14.0% | $7.9B+17.2% | $6.7B+33.9% | $5.0B |
| EPS (Basic) | $0.08-13.9% | $0.09+115.9% | $0.04-37.1% | $0.07-8.1% | $0.07+14.9% | $0.06+14.9% | $0.06+34.8% | $0.04 |
| EPS (Diluted) | $0.08-13.9% | $0.09+115.9% | $0.04-37.1% | $0.07-8.1% | $0.07+14.9% | $0.06+14.9% | $0.06+34.8% | $0.04 |
| Diluted Shares (Avg) | 120.89B-0.2% | 121.07B0.0% | 121.07B0.0% | 121.07B0.0% | 121.07B0.0% | 121.07B0.0% | 121.07B | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, SG&A Expenses.
SNPMF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $282.5B-4.7% | $296.5B+11.2% | $266.5B+5.1% | $253.6B+9.2% | $232.3B-5.3% | $245.2B+13.6% | $215.8B-3.4% | $223.4B |
| Current Assets | $75.8B-13.4% | $87.6B+25.4% | $69.8B+8.7% | $64.3B-12.4% | $73.3B-9.8% | $81.3B+36.9% | $59.4B | N/A |
| Cash & Equivalents | $13.5B-20.5% | $17.0B+27.0% | $13.4B+54.6% | $8.7B-46.7% | $16.3B-6.6% | $17.4B-2.8% | $17.9B+68.5% | $10.6B |
| Inventory | $35.4B+8.8% | $32.6B+39.6% | $23.3B-16.4% | $27.9B+3.9% | $26.8B-6.4% | $28.7B+27.3% | $22.5B | N/A |
| Accounts Receivable | $6.7B+22.9% | $5.5B+0.7% | $5.4B-30.5% | $7.8B-17.2% | $9.4B-27.5% | $13.0B | N/A | N/A |
| Goodwill | $937.2M-30.5% | $1.3B+2.1% | $1.3B+5.7% | $1.2B-1.0% | $1.3B-4.9% | $1.3B+45.0% | $915.0M | N/A |
| Total Liabilities | $146.8B-4.0% | $152.9B+17.2% | $130.5B+2.8% | $126.9B+18.0% | $107.5B-5.8% | $114.1B+18.7% | $96.1B-5.5% | $101.7B |
| Current Liabilities | $96.8B-3.8% | $100.6B+25.5% | $80.2B-3.8% | $83.3B+1.4% | $82.2B-7.7% | $89.1B+27.3% | $69.9B | N/A |
| Non-Current Liabilities | $50.0B-4.2% | $52.2B+3.9% | $50.3B+15.6% | $43.5B+75.3% | $24.8B-1.0% | $25.1B-4.2% | $26.2B | N/A |
| Long-Term Debt | $12.4B+1.1% | $12.3B+11.3% | $11.0B+56.2% | $7.1B-4.7% | $7.4B-13.5% | $8.6B-18.1% | $10.5B-29.0% | $14.7B |
| Total Equity | $113.8B-6.4% | $121.5B+6.2% | $114.4B+7.8% | $106.1B+1.7% | $104.3B-6.5% | $111.6B+9.0% | $102.4B-15.8% | $121.7B |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | $50.1B | N/A | N/A |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
SNPMF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $16.9B-52.3% | $35.3B+36.8% | $25.8B+16.5% | $22.2B-13.3% | $25.6B-12.8% | $29.3B-5.0% | $30.9B+20.8% | $25.6B |
| Depreciation & Amortization | $15.9B-12.2% | $18.2B+10.2% | $16.5B+4.6% | $15.7B-1.9% | $16.0B-9.4% | $17.7B+13.5% | $15.6B+4.9% | $14.9B |
| Investing Cash Flow | -$13.8Bn/m | -$22.8Bn/m | -$15.7Bn/m | -$17.4Bn/m | -$9.7Bn/m | -$22.3Bn/m | -$9.5Bn/m | -$18.0B |
| Financing Cash Flow | -$5.8Bn/m | -$9.1Bn/m | -$5.7Bn/m | -$12.2Bn/m | -$16.2Bn/m | -$8.7Bn/m | -$13.4B-1054.7% | $1.4B |
| Dividends Paid | $8.3B+49.7% | $5.5B+14.2% | $4.8B-27.0% | $6.6B-33.0% | $9.9B+96.3% | $5.0B+106.7% | $2.4B-35.0% | $3.7B |
| Share Buybacks | $605.9M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow.
SNPMF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.3%-1.2pp | 3.5%+2.8pp | 0.7%-2.3pp | 2.9%+0.1pp | 2.9%-0.2pp | 3.0%-1.0pp | 4.0%+1.2pp | 2.8% |
| Net Margin | 2.0%-0.6pp | 2.6%+1.0pp | 1.6%-0.3pp | 1.9%-0.2pp | 2.1%0.0pp | 2.2%-0.2pp | 2.4%+0.8pp | 1.6% |
| Return on Equity | 8.4%-0.9pp | 9.3%+4.8pp | 4.5%-3.3pp | 7.8%-0.8pp | 8.6%+1.5pp | 7.1%+0.5pp | 6.6%+2.4pp | 4.1% |
| Return on Assets | 3.4%-0.4pp | 3.8%+1.9pp | 1.9%-1.3pp | 3.3%-0.6pp | 3.9%+0.7pp | 3.2%+0.1pp | 3.1%+0.9pp | 2.3% |
| Current Ratio | 0.78-0.1x | 0.870.0x | 0.87+0.1x | 0.77-0.1x | 0.890.0x | 0.91+0.1x | 0.85 | N/A |
| Debt-to-Equity | 0.110.0x | 0.100.0x | 0.100.0x | 0.070.0x | 0.070.0x | 0.080.0x | 0.100.0x | 0.12 |
| Liabilities-to-Equity | 1.290.0x | 1.26+0.1x | 1.14-0.1x | 1.20+0.2x | 1.030.0x | 1.02+0.1x | 0.94+0.1x | 0.84 |
| Asset Turnover | 1.70+0.3x | 1.45+0.2x | 1.21-0.5x | 1.68-0.1x | 1.80+0.3x | 1.48+0.2x | 1.29-0.1x | 1.40 |
Not reported in any period shown, so not listed: Gross Margin, FCF Margin.
Note: The current ratio is below 1.0 (0.78), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where CHINA PETE & CHEM Ranks
Frequently Asked Questions
What is CHINA PETE & CHEM's annual revenue?
CHINA PETE & CHEM (SNPMF) reported $481.1B in total revenue for fiscal year 2022. This represents a 11.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is CHINA PETE & CHEM's revenue growing?
CHINA PETE & CHEM (SNPMF) revenue grew by 11.9% year-over-year, from $430.1B to $481.1B in fiscal year 2022.
Is CHINA PETE & CHEM profitable?
Yes, CHINA PETE & CHEM (SNPMF) reported a net income of $9.6B in fiscal year 2022, with a net profit margin of 2.0%.
What is CHINA PETE & CHEM's EBITDA?
CHINA PETE & CHEM (SNPMF) had EBITDA of $26.9B in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does CHINA PETE & CHEM have?
As of fiscal year 2022, CHINA PETE & CHEM (SNPMF) had $13.5B in cash and equivalents against $12.4B in long-term debt.
What is CHINA PETE & CHEM's operating margin?
CHINA PETE & CHEM (SNPMF) had an operating margin of 2.3% in fiscal year 2022, reflecting the profitability of core business operations before interest and taxes.
What is CHINA PETE & CHEM's net profit margin?
CHINA PETE & CHEM (SNPMF) had a net profit margin of 2.0% in fiscal year 2022, representing the share of revenue converted into profit after all expenses.
What is CHINA PETE & CHEM's return on equity (ROE)?
CHINA PETE & CHEM (SNPMF) has a return on equity of 8.4% for fiscal year 2022, measuring how efficiently the company generates profit from shareholder equity.
What is CHINA PETE & CHEM's operating cash flow?
CHINA PETE & CHEM (SNPMF) generated $16.9B in operating cash flow during fiscal year 2022, representing cash generated from core business activities.
What are CHINA PETE & CHEM's total assets?
CHINA PETE & CHEM (SNPMF) had $282.5B in total assets as of fiscal year 2022, including both current and long-term assets.
How much does CHINA PETE & CHEM spend on research and development?
CHINA PETE & CHEM (SNPMF) invested $1.9B in research and development during fiscal year 2022.
What is CHINA PETE & CHEM's current ratio?
CHINA PETE & CHEM (SNPMF) had a current ratio of 0.78 as of fiscal year 2022, which is below 1.0, which may suggest potential liquidity concerns.
What is CHINA PETE & CHEM's debt-to-equity ratio?
CHINA PETE & CHEM (SNPMF) had a debt-to-equity ratio of 0.11 as of fiscal year 2022. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is CHINA PETE & CHEM's liabilities-to-equity ratio?
CHINA PETE & CHEM (SNPMF) had a liabilities-to-equity ratio of 1.29 as of fiscal year 2022, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is CHINA PETE & CHEM's return on assets (ROA)?
CHINA PETE & CHEM (SNPMF) had a return on assets of 3.4% for fiscal year 2022, measuring how efficiently the company uses its assets to generate profit.
What is CHINA PETE & CHEM's P/E ratio?
CHINA PETE & CHEM (SNPMF) trades at 7.0x earnings, its market capitalization divided by $9.6B net income, FY2022. The market capitalization is $67.2B as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is CHINA PETE & CHEM's price-to-sales ratio?
CHINA PETE & CHEM (SNPMF) trades at 0.1x sales, its market capitalization divided by $481.1B revenue, FY2022. The market capitalization is $67.2B as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is CHINA PETE & CHEM's Piotroski F-Score?
CHINA PETE & CHEM (SNPMF) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are CHINA PETE & CHEM's earnings high quality?
CHINA PETE & CHEM (SNPMF) has an earnings quality ratio of 1.76x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can CHINA PETE & CHEM cover its interest payments?
CHINA PETE & CHEM (SNPMF) has an interest coverage ratio of 4.52x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.